We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Telecommunication Enhanced Asthma Management (TEAM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00958932
Recruitment Status : Unknown
Verified July 2011 by National Jewish Health.
Recruitment status was:  Active, not recruiting
First Posted : August 14, 2009
Last Update Posted : July 20, 2011
Kaiser Permanente
Information provided by:
National Jewish Health

August 13, 2009
August 14, 2009
July 20, 2011
September 2009
May 2012   (Final data collection date for primary outcome measure)
Medication adherence [ Time Frame: 12 months ]
Same as current
Complete list of historical versions of study NCT00958932 on ClinicalTrials.gov Archive Site
urgent care visits [ Time Frame: 12 months ]
Same as current
Not Provided
Not Provided
Telecommunication Enhanced Asthma Management
Telecommunication Enhanced Asthma Management
The primary aim of this project is to conduct a randomized practical clinical trial within a large health maintenance organization to test a telephone intervention designed to improve adherence to daily asthma medications and thereby improve asthma outcomes. The investigators hypothesize that adherence with inhaled corticosteroid medications in the TEAM intervention group will be greater than in the usual care group.

Asthma affects more than 15 million people in the United States. Inhaled corticosteroids (ICS), the ranking treatment-of-choice, are safe and highly efficacious in controlled trials, but adherence to ICS medications in real-world settings is poor in all patient groups, especially low-income and minority patients who experience the most morbidity from asthma. Children and adults with asthma take less than half of their prescribed ICS medication. One study found that only 44% of ICS prescriptions for children with asthma were filled. Even the most effective medications have little value if not taken as prescribed. Decreasing use of ICS has been repeatedly linked to poor asthma control and increasing health care utilization.

We will conduct a randomized, practical clinical trial to test the impact of a communication enhancement program for parents of 3-12 year old children with asthma in the largest health maintenance organization (HMO) within Colorado. Research in this setting has the significant advantage of not only establishing the utility of a behavior-changing strategy, but at the same time demonstrating that the strategy can be applied in a large healthcare system and sustained over time. The proposed intervention will be referred to here as the Telecommunication Enhanced Adherence Management (TEAM) program. This proposal builds upon ongoing efforts within Kaiser Permanente of Colorado (KPCO), the participating HMO, to use automated telecommunication technology to prevent diabetes, reduce cardiac risk, reduce calorie consumption, and increase exercise adherence, with the introduction of an intervention to increase adherence with daily ICS therapy. Speech Recognition (SR), the telecommunication technology used in this trial, has not previously been employed to promote adherence in a population of children treated for asthma within a large HMO. TEAM creates a theory-based enhanced communication program using SR with support from asthma care manager nurses. The Asthma Care Manager program already exists within KPCO, but with SR the frequency and quality of communication with parents is expected to improve significantly, resulting in more ICS medication refills, better persistence in ICS use, and improved asthma outcomes. Through SR calls, parents will be reminded and motivated about the importance of continued daily use of ICS medications, asked about their child's recent asthma symptoms, and given the opportunity to receive a call back from an asthma care manager or to place a request for a medication refill.

Early Phase 1
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Investigator)
Primary Purpose: Treatment
  • Behavioral: Speech recognition
    The TEAM intervention is a program to increase communication with families, provide feedback to families about their refill adherence, assess asthma symptoms, deliver health communication messages, encourage parents to ask questions of asthma care managers, and facilitate refilling ICS prescription. Speech recognition calls will be tailored to specific situations including new or re-issued ICS prescriptions, failure to fill an initial prescription, failure to refill, or failure to refill following an ED visit, hospitalization, or oral steroid burst resulting from an asthma exacerbation.
    Other Name: usual care
  • Behavioral: Speech recognition
    Automated, speech recognition telephone calls
    Other Name: usual care
  • Experimental: Speech recognition (TEAM intervention)
    Intervention: Behavioral: Speech recognition
  • Active Comparator: Speech recognition (Usual care)
    Intervention: Behavioral: Speech recognition
Bender BG, Cvietusa PJ, Goodrich GK, Lowe R, Nuanes HA, Rand C, Shetterly S, Tacinas C, Vollmer WM, Wagner N, Wamboldt FS, Xu S, Magid DJ. Pragmatic trial of health care technologies to improve adherence to pediatric asthma treatment: a randomized clinical trial. JAMA Pediatr. 2015 Apr;169(4):317-23. doi: 10.1001/jamapediatrics.2014.3280.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
Unknown status
May 2012
May 2012   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • 3-12 year old children with asthma requiring daily corticosteroid
Sexes Eligible for Study: All
3 Years to 12 Years   (Child)
Contact information is only displayed when the study is recruiting subjects
United States
1R01HL084067-01A1( U.S. NIH Grant/Contract )
Not Provided
Not Provided
Bruce Bender, National Jewish Health
National Jewish Health
Kaiser Permanente
Not Provided
National Jewish Health
July 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP